Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uro-vaxom after surgery for infected urolithiasis
KCT0007078Phase 4Completed
- Sponsor
- AJU PHARM Co., Ltd.
- Start
- Jul 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of OM-89 in Lithiasis, urinary tract infection (UTI), sponsored by AJU PHARM Co., Ltd.. Started Jul 2022; status: completed.
02
Drugs
OM-89
03
Conditions
Lithiasisurinary tract infection (UTI)
Beyond the preview
Go deeper on KCT0007078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007078.